4.6 Article

HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018

Related references

Note: Only part of the references are listed.
Article Virology

Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naive Individuals in Israel, 2010-2018

Tali Wagner et al.

Summary: Despite the low prevalence of HIV-1 in Israel, continuous waves of immigration have affected the local epidemic. Immigrants account for a significant portion of HIV-1 cases, with Israeli-born individuals mostly being men who have sex with men, while immigrants from Sub-Saharan Africa, Eastern Europe, and Central Asia are primarily people who inject drugs. The proportion of individuals from Sub-Saharan Africa has decreased over time, while those from Eastern Europe and Central Asia have increased significantly.

VIRUSES-BASEL (2022)

Article Virology

RDP5: a computer program for analyzing recombination in, and removing signals of recombination from, nucleotide sequence datasets

Darren P. Martin et al.

Summary: The RDP project has developed an automated recombination analysis tool, RDP5, which is faster and more efficient than its predecessor, RDP4. Users can now analyze larger and more complex datasets with minimal manual intervention, allowing for greater flexibility and output options.

VIRUS EVOLUTION (2021)

Article Microbiology

Characterization of HIV-1 Epidemic in Kyrgyzstan

Mariya V. Sivay et al.

Summary: Kyrgyzstan has a high rate of HIV-1 spread, with heterosexual transmission being the most common route of infection. The major HIV-1 variants identified in the study were CRF02_AG, CRF63_02A, and sub-subtype A6, showing rapid evolutionary dynamics in the Kyrgyz population since the mid-1990s. The study highlights the importance of molecular-epidemiological analysis for HIV-1 surveillance and treatment implementation to reduce new infections.

FRONTIERS IN MICROBIOLOGY (2021)

Article Microbiology

Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study

Ramyiadarsini Elangovan et al.

Summary: Global HIV-1 genetic diversity is a major obstacle to HIV vaccine development. Subtype-specific HIV-1 vaccines need to target common subtypes A, B, and C, as well as include env subtype E and pol subtype G for global coverage.

FRONTIERS IN MICROBIOLOGY (2021)

Review Immunology

HIV subtype diversity worldwide

Nicholas Bbosa et al.

CURRENT OPINION IN HIV AND AIDS (2019)

Article Infectious Diseases

Piloting a surveillance system for HIV drug resistance in the European Union

Marita J. W. van de Laar et al.

EUROSURVEILLANCE (2019)

Article Multidisciplinary Sciences

Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences

Soo-Yon Rhee et al.

SCIENTIFIC DATA (2018)

Article Infectious Diseases

Molecular epidemiology of HIV-1 infection in Europe: An overview

Apostolos Beloukas et al.

INFECTION GENETICS AND EVOLUTION (2016)

Article Multidisciplinary Sciences

A Population-Structured HIV Epidemic in Israel: Roles of Risk and Ethnicity

Zehava Grossman et al.

PLOS ONE (2015)

Article Biochemical Research Methods

AliView: a fast and lightweight alignment viewer and editor for large datasets

Anders Larsson

BIOINFORMATICS (2014)

Article Infectious Diseases

Current trends of HIV recombination worldwide

Katherine A. Lau et al.

INFECTIOUS DISEASE REPORTS (2013)

Review Biochemistry & Molecular Biology

The origin and diversity of the HIV-1 pandemic

Joris Hemelaar

TRENDS IN MOLECULAR MEDICINE (2012)

Article Multidisciplinary Sciences

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Diane E. Bennett et al.

PLOS ONE (2009)

Article Biochemistry & Molecular Biology

jModelTest: Phylogenetic model averaging

David Posada

MOLECULAR BIOLOGY AND EVOLUTION (2008)